Healthcare AI company Innovaccer closed a $275 million Series F funding round, bringing its fundraising total to date to $675 ...

GLP-1 drugs currently available for weight loss are administered as once-weekly injections. Verdiva Bio also aims to bring to patients once-a-week dosing, but in a more convenient pill. That would ...

Twentyeight Health, a digital women’s health company, has secured $10 million in Series A funding and launched new Medicaid partnerships with Aetna, AmeriHealth and Molina, the company announced ...

Pharmacies have a people problem. Pharmacists – the nerve center of the operation – are working harder than ever to keep up, burning out and leaving the profession. Overburdened by swelling ...

As the nation ushers in a GOP-controlled House and Senate, healthcare endures — a priority that transcends political currents. With 90 percent of American adults showing early signs of ...

A case can be made that metabolic medicine was the theme of the life sciences industry in 2024. Insatiable market demand fueled rocketing revenue growth for Novo Nordisk, which makes Wegovy, and ...

A notable marriage is occurring in the world of digital health: Transcarent has claimed Accolade for $621 million. But by no means is this a marriage of equals given how the latter is being taken ...

This week, Philadelphia-based behavioral health tech company Neuroflow completed its third acquisition. The company acquired Intermountain Health’s behavioral health risk analytics model to ...

While almost 84% of organizations have workplace wellness programs, there’s a concerning disconnect between these initiatives and actual employee health outcomes. Rising healthcare costs ...

Novo Nordisk’s collaboration with artificial intelligence startup Valo Health has focused on developing new drugs for cardiovascular disease. The pharmaceutical giant likes what it’s seen so ...

The Galapagos pipeline spans both oncology and immunology, but in recent years, the company has invested heavily in cancer cell therapy. The firm is now fully embracing the modality, announcing on ...